NO20055830L - Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme - Google Patents

Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme

Info

Publication number
NO20055830L
NO20055830L NO20055830A NO20055830A NO20055830L NO 20055830 L NO20055830 L NO 20055830L NO 20055830 A NO20055830 A NO 20055830A NO 20055830 A NO20055830 A NO 20055830A NO 20055830 L NO20055830 L NO 20055830L
Authority
NO
Norway
Prior art keywords
salts
proglitazone
methods
same
pharmaceutical compositions
Prior art date
Application number
NO20055830A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055830D0 (no
Inventor
Jie Zhu
Frantisek Picha
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of NO20055830D0 publication Critical patent/NO20055830D0/no
Publication of NO20055830L publication Critical patent/NO20055830L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20055830A 2003-05-13 2005-12-08 Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme NO20055830L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46983803P 2003-05-13 2003-05-13
PCT/EP2004/005133 WO2004101561A1 (en) 2003-05-13 2004-05-13 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same

Publications (2)

Publication Number Publication Date
NO20055830D0 NO20055830D0 (no) 2005-12-08
NO20055830L true NO20055830L (no) 2005-12-08

Family

ID=33452331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055830A NO20055830L (no) 2003-05-13 2005-12-08 Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme

Country Status (12)

Country Link
US (2) US7230016B2 (de)
EP (1) EP1622899B1 (de)
JP (1) JP2006528948A (de)
AT (1) ATE366733T1 (de)
AU (1) AU2004238537A1 (de)
CA (1) CA2525316A1 (de)
DE (1) DE602004007505T2 (de)
ES (1) ES2290709T3 (de)
IL (1) IL171875A0 (de)
NO (1) NO20055830L (de)
WO (1) WO2004101561A1 (de)
ZA (1) ZA200509155B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2005080387A2 (en) * 2004-02-20 2005-09-01 Synthon B.V. Processes for making pioglitazone and compounds of the processes
JP2008195625A (ja) * 2007-02-08 2008-08-28 Pharma Frontier Kk Ｇ蛋白質共役型レセプター抑制剤および医薬
KR101537830B1 (ko) 2007-09-14 2015-07-17 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 고혈압 치료용 티아졸리딘디온 유사체
US8304441B2 (en) 2007-09-14 2012-11-06 Metabolic Solutions Development Company, Llc Thiazolidinedione analogues for the treatment of metabolic diseases
WO2009071219A2 (en) * 2007-12-08 2009-06-11 Bayer Schering Pharma Aktiengesellschaft Oral dispersable tablet
JP5383123B2 (ja) * 2008-09-02 2014-01-08 株式会社トクヤマ ピオグリタゾン塩酸塩の製造方法
US20100060985A1 (en) 2008-09-09 2010-03-11 Fujifilm Corporation Method for producing polarizing plate, and automobile's windshield
TR201202048T2 (tr) * 2009-05-26 2012-04-24 Abdi̇ İbrahi̇m İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇@ Pioglitazon çözeltisi ile kaplanmış metformin.
KR20120107493A (ko) 2009-12-15 2012-10-02 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 대사성 질환의 치료를 위한 ｐｐａｒ 절약형 티아졸리딘디온염
US20120322728A1 (en) * 2009-12-15 2012-12-20 Metabolic Solutions Development Company, Llc Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone
RU2636483C2 (ru) * 2012-09-21 2017-11-23 Реоксин Дискавериз Груп, Инк. Ячейка для электролиза жидкости

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
FI91869C (fi) 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
EP0506273B1 (de) 1991-03-25 1995-05-31 Takeda Chemical Industries, Ltd. Verfahren zur Herstellung von Ethern
JPH07138258A (ja) 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
CA2195559A1 (en) 1994-08-10 1996-02-22 Takashi Sohda Thiazolidinedione derivatives, their production and use
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5814647A (en) 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
SE9702305D0 (sv) 1997-06-17 1997-06-17 Astra Ab New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
US7009057B2 (en) 2001-04-26 2006-03-07 Zentiva A.S. Method for obtaining pioglitazone as an antidiabetic agent
WO2004101560A1 (en) 2003-05-13 2004-11-25 Synthon B.V. Processes for making thiazolidinedione derivatives and compounds thereof
US7230016B2 (en) * 2003-05-13 2007-06-12 Synthon Ip Inc. Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same

Also Published As

Publication number Publication date
US20070203199A1 (en) 2007-08-30
WO2004101561A1 (en) 2004-11-25
NO20055830D0 (no) 2005-12-08
US20050054684A1 (en) 2005-03-10
EP1622899B1 (de) 2007-07-11
ATE366733T1 (de) 2007-08-15
US7230016B2 (en) 2007-06-12
DE602004007505T2 (de) 2008-03-13
AU2004238537A1 (en) 2004-11-25
CA2525316A1 (en) 2004-11-25
ZA200509155B (en) 2007-04-25
DE602004007505D1 (de) 2007-08-23
EP1622899A1 (de) 2006-02-08
ES2290709T3 (es) 2008-02-16
IL171875A0 (en) 2006-04-10
JP2006528948A (ja) 2006-12-28

Similar Documents

Publication Publication Date Title
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
NO20055018D0 (no) Anti-amyolide antistoffer, sammensetninger, fremgangsmater og anvendelser
ITPD20020138A0 (it) Composizione di sostanze a base terpenica, metodo di preparazione e metodo di dispersione in ambiente della medesima.
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
NO20065355L (no) Materialer som inneholoder en hul glucanpartikkel eller en celleveggkomponent som innkapsler en terpenkomponen, samt fremgangsmater for anvendelse av samme
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE407967T1 (de) Nukleierungsmittel
LTPA2018502I1 (lt) Per burną vartojamos kladribino kompozicijos
PL1628655T3 (pl) Kompozycje bakteriobójcze, sposoby i układy
WO2003088897A3 (en) Fab i inhibitors
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
WO2006083936A3 (en) Anti-ephb2 antibodies and methods using same
NO20055830D0 (no) Proglitazpnsalter, sa som pioglitazonsulfat og farmasoytiske sammensetnnger og fremgangsmater ved bruk av de samme
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
NO20075140L (no) Fremgangsmater og preparater for modulering av vaskulaer integritet
DK1611115T3 (da) Benzothiazolderivatforbindelser, sammensætninger og anvendelser deraf
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
NO20073071L (no) Benzotiazolformuleringer og anvendelse av disse
SE0300457D0 (sv) Novel compounds
BRPI0417205A (pt) composições farmacêuticas
WO2005094761A8 (en) Hair treatment compositions comprising a disaccharide, a di-acid and a source of ammonium ions
ATE391489T1 (de) Haarbehandlungszusammensetzungen
NO20053588L (no) Acylaminotiazol-derivater, fremstilling og anvendelse derav som beta-amyloidpeptid-produksjonsinhibitorer.